|
KIAA1310 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.497400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.663570E-01 |
| Normal-vs-Stage2 |
2.374000E-01 |
| Normal-vs-Stage3 |
4.527800E-01 |
| Normal-vs-Stage4 |
8.280400E-01 |
| Stage1-vs-Stage2 |
4.578600E-01 |
| Stage1-vs-Stage3 |
9.481400E-01 |
| Stage1-vs-Stage4 |
7.734400E-01 |
| Stage2-vs-Stage3 |
6.399800E-01 |
| Stage2-vs-Stage4 |
5.553000E-01 |
| Stage3-vs-Stage4 |
8.056200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.758200E-03 |
| Normal-vs-AfricanAmerican |
1.724010E-01 |
| Normal-vs-Asian |
8.440600E-01 |
| Caucasian-vs-AfricanAmerican |
5.971400E-01 |
| Caucasian-vs-Asian |
6.264000E-01 |
| AfricanAmerican-vs-Asian |
7.647600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.603600E-02 |
| Normal-vs-Female |
1.002160E-02 |
| Male-vs-Female |
2.640800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.981200E-01 |
| Normal-vs-Extreme_Weight |
3.867600E-01 |
| Normal-vs-Obese |
1.746120E-02 |
| Normal-vs-Extreme_Obese |
6.839600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.685200E-01 |
| Normal_Weight-vs-Obese |
8.749600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.924600E-01 |
| Extreme_Weight-vs-Obese |
1.192810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.789600E-01 |
| Obese-vs-Extreme_Obese |
4.612400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.753740E-02 |
| Normal-vs-Age(41-60Yrs) |
1.976820E-04 |
| Normal-vs-Age(61-80Yrs) |
2.762000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.239600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.218200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.084970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.367510E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.221400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.289760E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.723000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.20000000000065E-05 |
| Normal-VS-Type2 PRCC |
1.482980E-01 |
| Normal-VS-KIRP CIMP |
4.614400E-01 |
| Normal-VS-Unclassified PRCC |
6.964700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.38530000032478E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.177600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.371400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.262190E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.801900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.627600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.909000E-01 |
| Normal-vs-N1 |
8.561600E-02 |
| Normal-vs-N2 |
5.019000E-01 |
| N0-vs-N1 |
6.126200E-02 |
| N0-vs-N2 |
7.430600E-01 |
| N1-vs-N2 |
2.945200E-01 |
|
|
